About RAYDIAX
RAYDIAX is a company based in Magdeburg (Germany) founded in 2021 by Tim Pfeiffer, Andre Mewes, Robert Frysch, Benjamin Fritsch, and Thomas Hoffmann. RAYDIAX has raised $8.4 million across 2 funding rounds from investors including High-Tech Gründerfonds, bmp Ventures and IB Global. RAYDIAX offers products and services including RAYDIAX TACT and RSI Integration. RAYDIAX operates in a competitive market with competitors including Scholar Rock, SamanTree Medical, Lightpoint Medical, Ionpath and Fluxion Biosciences, among others.
- Headquarter Magdeburg, Germany
- Founders Tim Pfeiffer, Andre Mewes, Robert Frysch, Benjamin Fritsch, Thomas Hoffmann
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.4 M (USD)
in 2 rounds
-
Latest Funding Round
$5.86 M (USD), Series A
Mar 03, 2026
-
Investors
High-Tech Gründerfonds
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RAYDIAX
RAYDIAX offers a comprehensive portfolio of products and services, including RAYDIAX TACT and RSI Integration.
Combines CT and angiography for minimally invasive therapies and dose optimization.
Enables accurate robotic interventions with advanced X-ray viewing capabilities.
Funding Insights of RAYDIAX
RAYDIAX has successfully raised a total of $8.4M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.86 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in RAYDIAX
RAYDIAX has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include High-Tech Gründerfonds, bmp Ventures and IB Global.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
Venture capital is provided to early-stage and growth startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for RAYDIAX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RAYDIAX
Investment portfolio details for RAYDIAX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - RAYDIAX
Detailed financials for RAYDIAX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Raydiax Comparisons
Peer comparison for RAYDIAX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of RAYDIAX
RAYDIAX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scholar Rock, SamanTree Medical, Lightpoint Medical, Ionpath and Fluxion Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| Locked | Locked | Locked |
A surgical digital microscope for tumor resection is developed.
|
|
| Locked | Locked | Locked |
Intraoperative imaging devices for real-time cancer detection are developed.
|
|
| Locked | Locked | Locked |
Multiplexed ion beam imaging platform for tissue biopsies is developed.
|
|
| Locked | Locked | Locked |
Microfluidics-based tools for cellular analysis are provided.
|
|
| Locked | Locked | Locked |
Provider of virtual lens that generates High definition images without high-quality lenses
|
Detailed competitors of RAYDIAX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Raydiax
Complete news archive for RAYDIAX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RAYDIAX
RAYDIAX was founded in 2021 and raised its 1st funding round 2 years after it was founded.
RAYDIAX is headquartered in Magdeburg, Germany. It is registered at Magdeburg, Saxony-anhalt, Germany.
Thomas Hoffmann is the current CEO of RAYDIAX. They have also founded this company.
RAYDIAX is a funded company, having raised a total of $8.4M across 2 funding rounds to date.
RAYDIAX was founded in 2021 in Magdeburg, Germany, within the medical technology sector. A CT-guided therapy device is provided by the company, incorporating a navigation system alongside 2D and 3D X-ray live imaging. This equipment supports minimally invasive interventions for tumors. Operations focus on enhancing precision in such procedures through integrated imaging technologies.
RAYDIAX's top competitors include Scholar Rock, Ionpath and SamanTree Medical.
RAYDIAX offers RAYDIAX TACT and RSI Integration.
RAYDIAX has 4 investors. Key investors include High-Tech Gründerfonds, bmp Ventures, IB Global, and Getec.